← Leaderboards
Timothy McKinsey
University Of California Los Angeles
$12,803,870
Attributed
$21,000,263
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,000,263 · 11
By mechanism
R01$19,192,359 · 7
S10$960,459 · 2
R21$847,445 · 2
Top collaborators
- Deepak Srivastava5 shared
- Saptarsi Haldar4 shared
- Steven R Houser4 shared
- Hening Lin4 shared
- Thomas Martin Vondriska4 shared
- James E Bradner3 shared
- Carlin S Long2 shared
- Shelley Deanne Miyamoto2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tzung K Hsiai$18,151,559
- Thomas Martin Vondriska$19,397,244
- Soban Umar$2,400,392
- Paul M Thompson$55,589,208
- Ali Jazirehi$577,110
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultCardiacHeartProteinsHeart FailureRegulationSmall MoleculeProtein IsoformsPathogenesisHistone DeacetylaseBaseEpigenetic ProcessMolecularUnited StatesEnzymesDesignFamilyCardiac MyocytesRodent ModelPreventGenesIn VivoMediatingHistones
Grant awards (38)
HAT-Dependent Control of Cardiac Fibrosis$553,217
R01 · FY2025 · HL · contact PI
15-PGDH-Mediated Eicosanoid Degradation in Cardiac Fibrosis and Heart Failure$544,291
R01 · FY2025 · HL · contact PI
15-PGDH-Mediated Eicosanoid Degradation in Cardiac Fibrosis and Heart Failure$558,291
R01 · FY2024 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2023 · HL
Advanced Small Animal Ultrasound Imaging - Vevo F2$454,740
S10 · FY2023 · OD · contact PI
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF$747,930
R01 · FY2022 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.$745,398
R01 · FY2022 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2022 · HL
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.$495,235
R01 · FY2022 · DK · contact PI
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF$760,654
R01 · FY2021 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.$745,398
R01 · FY2021 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$720,487
R01 · FY2021 · HL
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.$538,105
R01 · FY2021 · DK · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$385,773
R01 · FY2021 · HL · contact PI
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF$773,007
R01 · FY2020 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.$745,398
R01 · FY2020 · HL · contact PI
Small molecule therapies targeting chromatin architecture in heart failure$734,487
R01 · FY2020 · HL
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.$510,062
R01 · FY2020 · DK · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$385,773
R01 · FY2020 · HL · contact PI
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF$798,875
R01 · FY2019 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.$787,023
R01 · FY2019 · HL · contact PI
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.$559,407
R01 · FY2019 · DK · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$385,773
R01 · FY2019 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins$800,056
R01 · FY2018 · HL · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$399,648
R01 · FY2018 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins$800,056
R01 · FY2017 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins$881,694
R01 · FY2016 · HL · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$388,750
R01 · FY2016 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins$827,495
R01 · FY2015 · HL · contact PI
Regulation of Cardiac Signaling by Class I Histone Deacetylases$382,918
R01 · FY2015 · HL · contact PI
Regulation of Chromatin Signaling in Heart Failure by BET Bromodomain Proteins$48,724
R01 · FY2015 · HL · contact PI
Small Animal Ultrasound Imager - Vevo 2100$505,719
S10 · FY2014 · OD
Regulation of Cardiac Signaling by Class I Histone Deacetylases$379,750
R01 · FY2014 · HL · contact PI
The Role of Histone Deacytelases in Right Ventricular Adaptation in Hypoplastic L$189,132
R21 · FY2014 · HL
Regulation of Cardiac Signaling by Class I Histone Deacetylases$367,710
R01 · FY2013 · HL · contact PI
The Role of Histone Deacytelases in Right Ventricular Adaptation in Hypoplastic L$244,586
R21 · FY2013 · HL
Isoform-Selective HDAC Inhibitors for Age-Associated Diastolic Dysfunction$182,602
R21 · FY2013 · AG · contact PI
Isoform-Selective HDAC Inhibitors for Age-Associated Diastolic Dysfunction$231,125
R21 · FY2012 · AG · contact PI